Genocea Biosciences Inc Net debt/EBITDA
What is the Net debt/EBITDA of Genocea Biosciences Inc?
The Net debt/EBITDA of Genocea Biosciences Inc is 2.20
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Health Care sector on NASDAQ compared to Genocea Biosciences Inc
What does Genocea Biosciences Inc do?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Companies with net debt/ebitda similar to Genocea Biosciences Inc
- Hydratec Industries NV has Net debt/EBITDA of 2.19
- AngloGold Ashanti has Net debt/EBITDA of 2.20
- Goodman Stapled Securities has Net debt/EBITDA of 2.20
- Valdor Technology International has Net debt/EBITDA of 2.20
- Karrie International has Net debt/EBITDA of 2.20
- The Panoply Plc has Net debt/EBITDA of 2.20
- Genocea Biosciences Inc has Net debt/EBITDA of 2.20
- GoPro has Net debt/EBITDA of 2.20
- United Parcel Service has Net debt/EBITDA of 2.21
- Qingdao Richen Foods Co has Net debt/EBITDA of 2.21
- S&P Global has Net debt/EBITDA of 2.22
- United Parcel Service has Net debt/EBITDA of 2.22
- Alltronics has Net debt/EBITDA of 2.22